Faculty of Pharmacy (FF) UNAIR and PUI-PT SCT Discuss Potential Collaboration in Transdermal Drug and Cosmetic Research and Development with Daewoong

The Faculty of Pharmacy, Universitas Airlangga (FF UNAIR) and the PUI-PT Skin Health and Cosmetic Technology (PUI-PT SCT) are exploring potential research collaborations with Daewoong Pharmaceutical Co., Ltd., a global pharmaceutical company from South Korea. The meeting, held online via Zoom on Wednesday, April 16, 2025, focused on exploring potential collaborative research in drug and cosmetic development, particularly in transdermal dosage forms.

This discussion marks the first step in building a strategic partnership between academic institutions and industry to develop innovations in the pharmaceutical and cosmetic fields. Transdermal dosage forms were chosen as the primary focus due to their significant potential for providing greater therapeutic effectiveness and ease of use for patients and consumers.

The meeting was attended by the leadership of FF UNAIR, members of PUI-PT SCT, and representatives of the Daewoong research and development team. Both parties shared their respective strengths and research focuses and discussed opportunities for synergy in formulation development, preclinical trials, and the commercialization of jointly researched products.

Through this discussion, both Faculty of Medicine (FF) UNAIR, PUI-PT SCT, and Daewoong expressed their initial commitment to continue intensive communication and establish a concrete framework for cooperation in the near future. This initiative is expected to encourage the transfer of knowledge and technology and strengthen the role of academics in addressing the challenge of meeting the need for high-quality and globally competitive pharmaceutical and cosmetic products.